Only a month remains before BIO-Europe 2008, the world's largest stand-alone partnering conference, takes place in Mannheim/Heidelberg, Germany, November 17-19. In response to the continuous growth and popularity of this well established biotechnology partnering event, EBD Group is announcing additional conference program highlights to offer even greater insight into a variety of important industry topics.
Maximizing Your Deal - The Business Case for Translational Medicine in Oncology:
Led by John Freshley, Compendia Bioscience, and featuring Dr. Ganesh Iyer, MDS Pharma; Aron Knickerbocker, Genentech; and Dr. Linda Pullan, Pullan Consulting; this session will explore the current and future state of translational medicine in oncology and dealmaking.
Biotech-CMO Partnerships - Ways to Create Value:
Klaus Binder, Binder Associates and Marcel Lubben, DSM Biologics; will confront the challenges in finding the right technologies and partners to develop and manufacture biopharmaceuticals. In addition, the panel will shed light on how biotech/pharma companies can identify partners and technologies to optimize resources and accelerate timelines.
Critical Issues to Consider when Entering the U.S. Market and Partnering with U.S. Companies:
Moderator Ray Briscuso, AdvaMed 2009 and panelists Dr. Steve Bryant, Genmab; Joe Dillon, The Mattson Jack Group; Christopher Yochim, AstraZeneca; and Jorn Mueller, NovoNordisk. This workshop will examine how to get timely U.S. Food and Drug Administration approval, position products for the best reimbursement and negotiate with governments, among other critical issues.
Full Story
15 Oct 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment